The benefits of dedicated Biocompatible UHPLC and chromatography column for analysis of Biomolecules

RECORD | Already taken place Fr, 22.1.2021

This webcast will showcase the challenges analytical laboratories face when analyzing biotherapeutics and how the hurdles of compromised sample integrity and surface interaction may be overcome.

Go to the webinar

Agilent Technologies: The benefits of dedicated Biocompatible UHPLC and chromatography column for analysis of Biomolecules

High performance liquid chromatography with optical detection or coupled to mass spectrometry are fundamental methods characterization and quality control of biopharmaceutical products. Biotherapeutic molecules represent a versatile class of compounds that need special attention for sample preparation, LC instrumentation, and type of chromatography columns used.

Presenter: Manu Grover (Business Manager, Agilent Technologies, India)

Presenter: Vinayak AK (Product Specialist, Agilent Technologies, India)

Presenter: Cornelia Vad (Senior Product Manager Analytical HPLC, Agilent Technologies)

Presenter: Dr. Andrew Coffey (Senior Applications Chemist, Agilent Technologies)

Agilent Technologies

The benefits of dedicated Biocompatible UHPLC and chromatography column for analysis of Biomolecules

Related content

Overcoming Strong Solvent Effects in the Analysis of Vepdegestrant

Identification of Double Bond Positions and Relative Acyl Chain Positions in Egg Yolk Phosphatidylcholines Using OAD-TOF System

High Molecular-Weight Polysaccharide Characterization by SEC-MALS Using GTxResolve™ 1000 and 2000 Å SEC Columns

Development and Optimization for a Comprehensive LC/MS/MS Method for the Detection of 74 PFAS Compounds

PFAS in Biota: Risk Context & Robust Analytical Solutions